Probabilistic analysis results of the NPP cost-effectiveness
NPP | Combined | SCU/HDU | NICU | ||||||
Point estimate | Lower 95% limit | Upper 95% limit | Point estimate | Lower 95% limit | Upper 95% limit | Point estimate | Lower 95% limit | Upper 95% limit | |
Incremental implementation costs, £ | 294 | 32 | 808 | 553 | 134 | 1277 | 98 | 57 | 149 |
Incremental lifetime costs, £ | −943 | −1486 | −469 | −909 | −1514 | −362 | −867 | −1443 | −357 |
Incremental total costs, £ | −649 | −1284 | 35 | −356 | −1131 | 539 | −769 | −1344 | 258 |
Incremental QALYs | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 | 0.02 |
Net monetary benefit*, £ | 886 | 130 | 1621 | 586 | −372 | 1475 | 987 | 355 | 1675 |
*We used a willingness-to-pay threshold of £20 000 per QALY gained.
HDU, high dependency unit; NICU, neonatal intensive care unit; NPP, National PReCePT Programme; PReCePT, Preventing Cerebral Palsy in Pre Term labour; QALYs, quality-adjusted life-years; SCU, special care unit.